GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection

Helicobacter. 2022 Jun;27(3):e12884. doi: 10.1111/hel.12884. Epub 2022 Mar 7.

Jannis Kountouras¹, Evangelos Kazakos^{1

2}, Stergios A Polyzos³, Dimitrios Chatzopoulos¹, Maria Tzitiridou-Chatzopoulou^{1

2}, Michael Doulberis^{1

3

4}, Apostolis Papaefthymiou^{1

3

5}, Elisabeth Vardaka^{1

6}

¹ Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Macedonia, Greece.
² School of Healthcare Sciences, Midwifery Department, University of West Macedonia, Koila, Kozani, Macedonia, Greece.
³ First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.
⁴ Division of Gastroenterology and Hepatology, Medical University Department, Kantonsspital Aarau, Aarau, Switzerland.
⁵ Department of Gastroenterology, University Hospital of Larisa, Larisa, Thessaly, Greece.
⁶ Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, Thessaloniki, Macedonia, Greece.

No abstract available

Publication types